371 results
Page 3 of 19
8-K
EX-99.1
d36uyqs8phur
12 Aug 21
LINEAGE REPORTs SECOND QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS ADDITIONAL PROGRESS FROM CLINICAL CELL THERAPY PROGRAMS
4:10pm
DEFA14A
7f08osjw5
3 Aug 21
Additional proxy soliciting materials
5:05pm
8-K
EX-99.1
4s9 hanlp9k52
1 Jun 21
Lineage Cell Therapeutics Reports Additional Cases of Retinal Tissue Restoration In Dry Amd Patients Treated with OpregenĀ® Rpe Cells
7:00am
8-K
EX-99.1
jy6eu5
13 May 21
LINEAGE REPORTs FIRST QUARTER 2021 FINANCIAL RESULTS AND HIGHLIGHTS
4:10pm
8-K
EX-99.1
06df8t18e 8ef96hd
3 May 21
OpREGENĀ® CLINICAL DATA CONTINUES TO DEMONSTRATE IMPROVEMENTS IN PATIENTS WITH DRY AMD WITH GEOGRAPHIC ATROPHY
5:00pm
8-K
EX-99.1
cv4rpl0yzc49fwvvk
11 Mar 21
LINEAGE CELL THERAPEUTICS REPORTs FOURTH QUARTER AND FULL YEAR 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE
4:15pm
8-K
EX-99.1
22xuf
16 Nov 20
Lineage Cell Therapeutics Presents New OpregenĀ® Data for Dry Amd with Ga at 2020 American Academy of Ophthalmology Annual Meeting
8:30am
8-K
EX-10.1
3oqppg pcmcsgp
14 Sep 20
Termination of a Material Definitive Agreement
9:00am
DEFA14A
uhktm
10 Aug 20
Additional proxy soliciting materials
12:00am